Dr. Nick Maskalenko
Postdoctoral Associate
Fox Chase Cancer Center
In this webinar, Dr. Nick Maskalenko, Postdoc Associate at Fox Chase Cancer Center, will discuss the role of natural killer (NK) cells in cancer immunotherapy and how polymorphisms of the Fc gamma receptor CD16 factor into antibody dependent cellular cytotoxicity (ADCC) responses against tumor cells.
Furthermore, he will explore the unique features and advantages of xCELLigence Real-Time Cell Analysis (RTCA) technology in cancer immunotherapy, the important value of monitoring real-time cell killing, and how the kinetics of cell killing can provide valuable insight into effector processes that can be exploited to improve NK cell cytotoxicity.
Key learning objectives
Who should attend?
For Research Use Only. Not for use in diagnostic procedures.